Advertisement

Topics

Latest Endocrinology NewsRSS

20:54 EDT 22nd July 2017 | BioPortfolio

Europe Endocrine Function Market 2021: France, Germany, Italy, Spain, UKSupplier Shares and Strategies, Volume and Sales Segment Forecasts [Report Updated: 12072017] Prices from USD $6500

This new 310page report from VPGMarketResearch provides a comprehensive analysis of the European endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH,...

Top takeaways from the Heart in Diabetes conference

Endocrine Today has compiled a list of the top five news stories posted from the Heart in Diabetes conference, held July 14 to 16 in Philadelphia. Healio.com/Endocrinology readers were interested in the cardiorenal syndrome, new developments in heart failure research, and much more.

Neurocrine Biosciences Announces the Appointment of Julie Cooke as Chief People Officer

SAN DIEGO, July 21, 2017 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, announced that Julie Cooke is joining as Chief People Officer in September 2017 and will be a member of the Management Committee.   "Neurocrine is delighted to welcome Julie Cooke as our Chief People Officer to lead our...

EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

DARMSTADT, Germany and NEW YORK, July 20, 2017 /PRNewswire/ -- Not intended for UK-based media    If approved, avelumab could be the first immunotherapy treatment indicated for this rare and aggressive skin cancer in the EU    Decision by the EC is expected in the third quart...

Aeterna Zentaris Forms Strategic Review Committee and Appoints Michael Ward as CEO

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), announced today that it has formed a special committee of independent directors (the “Strategic Review Committee”) to consider and evaluate various strategic and financing alternatives available to the Company to maximize shareholder value, including continuing to execute on its ...

Sage Therapeutics to Report Second Quarter 2017 Financial Results on Thursday, August 3, 2017

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the company will host a conference call and live webcast on Thursday, August 3, 2017 at 4:30 pm ET to report its second quarter 2017 financial results and to discuss rec...

NeuroVia Closes Series A Financing Round of $14M to Develop Novel Treatment Option for X-ALD Disease

Funds Will Allow NeuroVia to Advance Lead Candidate NV1205 into a Multi-National Clinical Proof of Concept Program NeuroVia, Inc., a biopharmaceutical company focused on developing innovative therapies for rare genetic neurological diseases, announced the closing of a Series A financing round of $14 million. The financing was co-led by Novartis Venture...

Churchill Pharmaceuticals Announces NDA Filing Acceptance for YONSA™ by the U.S. FDA

KING OF PRUSSIA, Pa., July 20, 2017 /PRNewswire/ -- Churchill Pharmaceuticals, LLC (Churchill), a privately held company devoted to expanding treatment options with oral oncology agents, announces that the New Drug Application (NDA) for YONSA™ (abiraterone acetate) ultramicrosize tablets has been accepted for filing by the U.S. Food and Drug Administration (FDA). Under the Prescription Drug User...

Aeterna’s Filing Of Approval For Macrilen Tells Investors To Stay Away

Recently, Aeterna Zentaris (NASDAQ:AEZS) announced that the FDA had accepted its NDA for Macrilen. That is because the company is seeking marketing approval for Macrilen for the evaluation of growth hormone deficiency. The company filing of the NDA is in… Continue Reading →

Inventor and InventHelp Client Develops Cane Reminder (FLA-2856)

InventHelp, a leading invention firm, is submitting the E-CANE to companies in the hopes of a good faith review. PITTSBURGH, PA (PRWEB) July 19, 2017 "Individuals with various memory disorders may tend to lose their canes more frequently than those without such disorders," said an inventor from Lake Park, Fla. "I came up with this idea as a way to keep individuals from leaving thei...

BDNF/NT 3 Growth Factors Receptor GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1 Pipeline Review, H2 2017 [Report Updated: 11072017] Prices from USD $3500

BDNF/NT 3 Growth Factors Receptor GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1 Pipeline Review, H2 2017SummaryBDNF/NT 3 Growth Factors Receptor GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1 pipeline Target consti...

Down Syndrome Pipeline Review, H2 2017 [Report Updated: 11072017] Prices from USD $2000

Down Syndrome Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Down Syndrome Pipeline Review, H2 2017, provides an overview of the Down Syndrome Genetic Disorders pipeline landscape.Down syndrome is a genetic disorder that causes lifelong mental retardation, developmental delays and other problems. Down syndrome varies in severity...

Nasopharyngitis Common Cold Pipeline Review, H2 2017 [Report Updated: 11072017] Prices from USD $2000

Nasopharyngitis Common Cold Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasopharyngitis Common Cold Pipeline Review, H2 2017, provides an overview of the Nasopharyngitis Common Cold Ear Nose Throat Disorders pipeline landscape.Nasopharyngitis also known as common cold is an infectious, inflammatory condition that affects the ...

Otitis Media Pipeline Review, H2 2017 [Report Updated: 11072017] Prices from USD $2000

Otitis Media Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Otitis Media Pipeline Review, H2 2017, provides an overview of the Otitis Media Ear Nose Throat Disorders pipeline landscape.Otitis media OM is any inflammation of the middle ear, the airfilled space behind the eardrum that contains the tiny vibrating bones of the ear. ...

PraderWilli Syndrome PWS Pipeline Review, H2 2017 [Report Updated: 11072017] Prices from USD $2000

PraderWilli Syndrome PWS Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide PraderWilli Syndrome PWS Pipeline Review, H2 2017, provides an overview of the PraderWilli Syndrome PWS Genetic Disorders pipeline landscape.PraderWilli Syndrome PWS is a rare genetic disorder present at birth that results in a number of physical, mental and...

Counsyl Announces Industry Leading Enhancements to Expanded Carrier Screening Panel

Counsyl Foresight™ Carrier Screen features unmatched detection of serious inheritable conditions Counsyl, a DNA testing and genetic counseling company, today unveiled significant enhancements to its flagship expanded carrier screening (ECS) product,

Degenerative Disc Disease Pipeline Review, H2 2017 [Report Updated: 18072017] Prices from USD $2000

Degenerative Disc Disease Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease Pipeline Review, H2 2017, provides an overview of the Degenerative Disc Disease Musculoskeletal Disorders pipeline landscape.Degenerative disc disease is refers to degeneration of intervertebral discs of the spinal column. The main...

Hypoglycemia Pipeline Review, H2 2017 [Report Updated: 18072017] Prices from USD $2000

Hypoglycemia Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypoglycemia Pipeline Review, H2 2017, provides an overview of the Hypoglycemia Metabolic Disorders pipeline landscape.Hypoglycemia is a condition characterized by an abnormally low level of blood sugar glucose. Symptoms of hypoglycemia include tachycardia, anxiety, sha...

Secondary Hyperparathyroidism Pipeline Review, H2 2017 [Report Updated: 18072017] Prices from USD $2000

Secondary Hyperparathyroidism Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism Pipeline Review, H2 2017, provides an overview of the Secondary Hyperparathyroidism Hormonal Disorders pipeline landscape.Secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyr...

Iron Deficiency Anemia Pipeline Review, H2 2017 [Report Updated: 18072017] Prices from USD $2000

Iron Deficiency Anemia Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Iron Deficiency Anemia Pipeline Review, H2 2017, provides an overview of the Iron Deficiency Anemia Hematological Disorders pipeline landscape.Anemia is a condition in which the body does not have enough healthy red blood cells. Iron helps make red blood cells...

Amyloidosis Pipeline Review, H2 2017 [Report Updated: 18072017] Prices from USD $2000

Amyloidosis Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis Pipeline Review, H2 2017, provides an overview of the Amyloidosis Metabolic Disorders pipeline landscape.Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning of th...

Uterine Leiomyoma Uterine Fibroids Pipeline Review, H2 2017 [Report Updated: 18072017] Prices from USD $2000

Uterine Leiomyoma Uterine Fibroids Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uterine Leiomyoma Uterine Fibroids Pipeline Review, H2 2017, provides an overview of the Uterine Leiomyoma Uterine Fibroids Non Malignant Disorders pipeline landscape.Uterine fibroids are benign tumors that originate in the uterus womb. Although th...

Insulin Resistance Pipeline Review, H2 2017 [Report Updated: 18072017] Prices from USD $2000

Insulin Resistance Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Insulin Resistance Pipeline Review, H2 2017, provides an overview of the Insulin Resistance Metabolic Disorders pipeline landscape.Insulin resistance IR is a condition in which the body's cells become resistant to the effects of insulin. This occurs when insulin l...

Phenylketonuria PKU Pipeline Review, H2 2017 [Report Updated: 18072017] Prices from USD $2000

Phenylketonuria PKU Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Phenylketonuria PKU Pipeline Review, H2 2017, provides an overview of the Phenylketonuria PKU Metabolic Disorders pipeline landscape.Phenylketonuria also called PKU, is a rare inherited disorder that causes an amino acid called phenylalanine to build up in body. ...

Sarcopenia Pipeline Review, H2 2017 [Report Updated: 18072017] Prices from USD $2000

Sarcopenia Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia Pipeline Review, H2 2017, provides an overview of the Sarcopenia Musculoskeletal Disorders pipeline landscape.Sarcopenia is defined as the loss of mass and muscular function with age. Symptoms include obesity, difficulty walking or moving about, lack of strengt...

Quick Search
Advertisement
 

review and buy Endocrinology market research data and corporate reports here